| 产品详情 |
| Edit |   |
| Product Name | Synuclein, gamma, Recombinant, Mouse (BCSG1, SYN) |
| Description | Highly Purified (~95%). Parkinson's disease (PD) is a common neurodegenerative disorder with a lifetime incidence of ~2 percent; the clinical manifestations of this neurodegenerative disorder include resting tremor, muscular rigidity, bradykinesia, and postural instability. A relatively specific pathological feature accompanying the neuronal degeneration is an intracytoplasmic inclusion body, known as the Lewy body. A mutation was identified in the a- synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, this mutation may cause a conformational change that renders a-synuclein more prone to self aggregation and deposition in Lewy bodies, which finally leads to oxidative stress and misfolding of -synuclein. Parkin gene, mutations in this gene are reported in early autosomal-recessive form of PD, however these mutations do not degenerate Lewy bodies. The Parkin gene product (Parkin) is involved in protein degradation as a ubiquitin protein li |
| Size | 50ug |
| Concentration | n/a |
| Applications | ELISA WB |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 209227 |
| Price | |
| Order / More Info | Synuclein, gamma, Recombinant, Mouse (BCSG1, SYN) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|